The JAK2-V617F mutation and essential thrombocythemia features in a subset of patients with refractory anemia with ring sideroblasts (RARS)

被引：48

作者：

Boissinot, Marjorie ^{[1
]}

Garand, Richard ^{[1
]}

Hamidou, Mohamed ^{[1
]}

Hermouet, Sylvie ^{[1
]}

机构：

[1] CHU Nantes, Hematol Lab, Inst Biol, F-44093 Nantes, France

来源：

BLOOD | 2006年 / 108卷 / 05期

关键词：

D O I：

10.1182/blood-2006-03-008227

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1781 / 1782

页数：2

共 8 条

[1]

BRUNNING RD, 2001, WHO CLASSIFICATION T, P69

[2]

Dobo I, 2004, HAEMATOLOGICA, V89, P1207

[3] A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera [J].

James, C ;

Ugo, V ;

Le Couédic, JP ;

Staerk, J ;

Delhommeau, F ;

Lacout, C ;

Garçon, L ;

Raslova, H ;

Berger, R ;

Bennaceur-Griscelli, A ;

Villeval, JL ;

Constantinescu, SN ;

Casadevall, N ;

Vainchenker, W .

NATURE, 2005, 434 (7037) :1144-1148

[4]

LIPPERT E, 2006, BLOOD 0525, DOI DOI 10.1182/BLOOD-2006-01-013540

[5] The JAK2 V617F tyrosine kinase mutation in myelodysplastic syndromes (MDS) developing myelofibrosis indicates the myeloproliferative nature in a subset of MDS patients [J].

Ohyashiki, K ;

Aota, Y ;

Akahane, D ;

Gotoh, A ;

Miyazawa, K ;

Kimura, Y ;

Ohyashiki, JH .

LEUKEMIA, 2005, 19 (12) :2359-2360

[6]

Schmitt-Graeff A, 2002, HAEMATOLOGICA, V87, P392

[7] Ringed sideroblasts with thrombocytosis: an uncommon mixed myelodysplastic/myeloproliferative disease of older adults [J].

Shaw, GR .

BRITISH JOURNAL OF HAEMATOLOGY, 2005, 131 (02) :180-184

[8] The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes [J].

Steensma, DP ;

Dewald, GW ;

Lasho, TL ;

Powell, HL ;

McClure, RF ;

Levine, RL ;

Gilliland, DG ;

Tefferi, A .

BLOOD, 2005, 106 (04) :1207-1209

← 1 →